Skip to contentS
Selectis Health, Inc.
S
GBCSSelectis Health, Inc. Q4 2024 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$10.40M$10.40Mderived+13.0% vs Q4 2023 Net Income-$576.46K-$576.46KderivedN/M vs Q4 2023 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Selectis Health, Inc. · CIK 727346 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Operating Incomederived-$97,259N/M Operating Cash Flowderived-$423,361N/M Free Cash Flowderived-$433,197N/M Margins · derivedOperating margin-0.9%+31.6 pt vs Q4 2023
Net margin-5.5%+33.9 pt vs Q4 2023
ended Dec 31, 2024 · filed Apr 15, 2025 · 105 d after period end